Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Chubb
AstraZeneca
Deloitte
Fuji
US Army
Dow
Express Scripts
Medtronic

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,645,963

« Back to Dashboard

Which drugs does patent 6,645,963 protect, and when does it expire?

Patent 6,645,963 protects ISTALOL and is included in one NDA.

This patent has eight patent family members in seven countries.
Summary for Patent: 6,645,963
Title: Prolonged-action eye drop
Abstract:Eye drops containing a .beta.-blocker such as cartelol hydrochloride are improved in the penetration of the .beta.-blocker into the eye and the retention thereof in the eye tissues by the incorporation of a C.sub.3-7 fatty acid such as sorbic acid to the eye preparations.
Inventor(s): Higashiyama; Masayo (Kobe, JP), Ohtori; Akira (Kobe, JP)
Assignee: Senju Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:09/802,849
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

Drugs Protected by US Patent 6,645,963

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bausch And Lomb ISTALOL timolol maleate SOLUTION/DROPS;OPHTHALMIC 021516-001 Jun 4, 2004 AT2 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,645,963

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan9-302802Nov 05, 1997
Japan10-250009Sep 03, 1998

Non-Orange Book US Patents Family Members for Patent 6,645,963

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,335,335 Prolonged-action eye drop ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,645,963

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2307303 ➤ Subscribe
China 1124842 ➤ Subscribe
China 1278162 ➤ Subscribe
Germany 69839152 ➤ Subscribe
European Patent Office 1029537 ➤ Subscribe
Spain 2297894 ➤ Subscribe
Japan 4377052 ➤ Subscribe
World Intellectual Property Organization (WIPO) 9922715 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
US Department of Justice
Fish and Richardson
Accenture
Baxter
Teva
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot